Inogen (INGN) Tops Q2 EPS by 21c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Inogen, Inc (INGN) PT Raised to $254 at Needham & Company
August 8, 2018 6:40 AM EDTNeedham & Company raised its price target on Inogen, Inc (NASDAQ: INGN) to $254.00 (from $215.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "INGN significantly beat consensus revenue, EBITDA, and EPS expectations in 2Q18 and management raised guidance for revenue, EBITDA... More
